319 related articles for article (PubMed ID: 36717220)
1. Targeting m
Bao Y; Zhai J; Chen H; Wong CC; Liang C; Ding Y; Huang D; Gou H; Chen D; Pan Y; Kang W; To KF; Yu J
Gut; 2023 Aug; 72(8):1497-1509. PubMed ID: 36717220
[TBL] [Abstract][Full Text] [Related]
2. METTL3 Inhibits Antitumor Immunity by Targeting m
Chen H; Pan Y; Zhou Q; Liang C; Wong CC; Zhou Y; Huang D; Liu W; Zhai J; Gou H; Su H; Zhang X; Xu H; Wang Y; Kang W; Kei Wu WK; Yu J
Gastroenterology; 2022 Oct; 163(4):891-907. PubMed ID: 35700773
[TBL] [Abstract][Full Text] [Related]
3. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
Wang L; Zhu L; Liang C; Huang X; Liu Z; Huo J; Zhang Y; Zhang Y; Chen L; Xu H; Li X; Xu L; Kuang M; Wong CC; Yu J
J Hepatol; 2023 Nov; 79(5):1185-1200. PubMed ID: 37459919
[TBL] [Abstract][Full Text] [Related]
4. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.
Wang S; Gao S; Zeng Y; Zhu L; Mo Y; Wong CC; Bao Y; Su P; Zhai J; Wang L; Soares F; Xu X; Chen H; Hezaveh K; Ci X; He A; McGaha T; O'Brien C; Rottapel R; Kang W; Wu J; Zheng G; Cai Z; Yu J; He HH
Gastroenterology; 2022 Apr; 162(4):1183-1196. PubMed ID: 34968454
[TBL] [Abstract][Full Text] [Related]
5. ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy.
Zhai J; Chen H; Wong CC; Peng Y; Gou H; Zhang J; Pan Y; Chen D; Lin Y; Wang S; Kang W; To KF; Chen Z; Nie Y; He HH; Sung JJ; Yu J
Gastroenterology; 2023 Aug; 165(2):445-462. PubMed ID: 37169182
[TBL] [Abstract][Full Text] [Related]
6. Methionine deficiency facilitates antitumour immunity by altering m
Li T; Tan YT; Chen YX; Zheng XJ; Wang W; Liao K; Mo HY; Lin J; Yang W; Piao HL; Xu RH; Ju HQ
Gut; 2023 Mar; 72(3):501-511. PubMed ID: 35803704
[TBL] [Abstract][Full Text] [Related]
7. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
8. Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability.
Wu T; Zhang X; Liu X; Cai X; Shen T; Pan D; Liang R; Ding R; Hu R; Dong J; Li F; Li J; Xie L; Wang C; Geng S; Yang Z; Xing L; Li Y
BMC Med; 2023 Apr; 21(1):161. PubMed ID: 37106440
[TBL] [Abstract][Full Text] [Related]
9. RNA N
Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
[TBL] [Abstract][Full Text] [Related]
10.
Kang X; Liu C; Ding Y; Ni Y; Ji F; Lau HCH; Jiang L; Sung JJ; Wong SH; Yu J
Gut; 2023 Nov; 72(11):2112-2122. PubMed ID: 37491158
[No Abstract] [Full Text] [Related]
11.
Fong W; Li Q; Ji F; Liang W; Lau HCH; Kang X; Liu W; To KK; Zuo Z; Li X; Zhang X; Sung JJ; Yu J
Gut; 2023 Nov; 72(12):2272-2285. PubMed ID: 37770127
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity.
Huang TX; Tan XY; Huang HS; Li YT; Liu BL; Liu KS; Chen X; Chen Z; Guan XY; Zou C; Fu L
Gut; 2022 Feb; 71(2):333-344. PubMed ID: 33692094
[TBL] [Abstract][Full Text] [Related]
13. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
[TBL] [Abstract][Full Text] [Related]
14. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
Front Immunol; 2021; 12():667177. PubMed ID: 34025668
[TBL] [Abstract][Full Text] [Related]
15. DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis.
Yan R; Li J; Xiao Z; Fan X; Liu H; Xu Y; Sun R; Liu J; Yao J; An G; Shi Y; Ge Y
Cell Mol Gastroenterol Hepatol; 2023; 15(2):463-485. PubMed ID: 36309200
[TBL] [Abstract][Full Text] [Related]
16. NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer.
Wang S; Kuai Y; Lin S; Li L; Gu Q; Zhang X; Li X; He Y; Chen S; Xia X; Ruan Z; Lin C; Ding Y; Zhang Q; Qi C; Li J; He X; Pathak JL; Zhou W; Liu S; Wang L; Zheng L
BMC Med; 2023 Mar; 21(1):115. PubMed ID: 36978108
[TBL] [Abstract][Full Text] [Related]
17. m
Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
[TBL] [Abstract][Full Text] [Related]
18. Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer.
Li YY; Wang XY; Li Y; Wang XM; Liao J; Wang YZ; Hong H; Yi W; Chen J
Cell Oncol (Dordr); 2023 Jun; 46(3):777-791. PubMed ID: 36920728
[TBL] [Abstract][Full Text] [Related]
19. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer.
Ghonim MA; Ibba SV; Tarhuni AF; Errami Y; Luu HH; Dean MJ; El-Bahrawy AH; Wyczechowska D; Benslimane IA; Del Valle L; Al-Khami AA; Ochoa AC; Boulares AH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495297
[TBL] [Abstract][Full Text] [Related]
20. Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.
Zhou Q; Peng Y; Ji F; Chen H; Kang W; Chan LS; Gou H; Lin Y; Huang P; Chen D; Wei Q; Su H; Liang C; Zhang X; Yu J; Wong CC
Nat Commun; 2023 Aug; 14(1):4677. PubMed ID: 37542037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
